ArticleClinical and experimental immunology2008
Special anniversary review: twenty-five years of human immunodeficiency virus research: successes and challenges.
Article in Clinical and experimental immunology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed.
- Causes of hospitalization among people living with HIV in a tertiary-care hospital in Bogotá, Colombia, 2018-2024.PloS one · 2026Article
- Determinants of hemoglobin level and time to default from Highly Active Antiretroviral Therapy (HAART) for adult clients living with HIV under treatment; a retrospective cohort study design.Scientific reports · 2024Article
- Article
- Using C. elegans to discover therapeutic compounds for ageing-associated neurodegenerative diseases.Chemistry Central journal · 2015Review
- Microdevices for examining immunological responses of single cells to HIV.Bioscience reports · 2014Review
- Oral health associated with quality of life of people living with HIV/AIDS in Brazil.Health and quality of life outcomes · 2014Article
- Expression and activation of intracellular receptors TLR7, TLR8 and TLR9 in peripheral blood monocytes from HIV-infected patients.Colombia medica (Cali, Colombia) · 2013Article
- Article
- Smallest organism; highest threat.Materia socio-medica · 2012Article
- Expanding ART for treatment and prevention of HIV in South Africa: estimated cost and cost-effectiveness 2011-2050.PloS one · 2012Article
- Antiretroviral therapy initiated soon after HIV diagnosis as standard care: potential to save lives?HIV/AIDS (Auckland, N.Z.) · 2011Article
- Highly active antiretroviral treatment as prevention of HIV transmission: review of scientific evidence and update.Current opinion in HIV and AIDS · 2010Review
- Highly active antiretroviral treatment for the prevention of HIV transmission.Journal of the International AIDS Society · 2010Article
- Update on animal models for HIV research.European journal of immunology · 2009Article
- HLA-associated clinical progression correlates with epitope reversion rates in early human immunodeficiency virus infection.Journal of virology · 2009Article
- 25 years of HIV research on virology, virus restriction, immunopathogenesis, genes and vaccines.Clinical and experimental immunology · 2008Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
Abstract
During 25 years of research since HIV-1 was first identified in Paris, there have been great advances in our understanding of the virus and of the immune system. Practical advances include the early development of diagnostic tests of infection that made blood donation safe, and since 1996, combination anti-retroviral therapy that has great reduced incidence of AIDS in HIV-infected people who have access to the drugs. HIV prevention through behavioural change has been successful, and we do not yet have any safe and efficacious microbicides or vaccines.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.